PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs

Circulation Research

Volumn 79, Issue 3, 1996, Pages 415-423

  Mizumura, Tsuneo ^a   Auchampach, John A ^b   Linden, Joel ^b   Bruns, Robert F ^c   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

adenosine receptors; allosteric enhancers; glibenclamide; ischemic preconditioning

Indexed keywords

2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; GLIBENCLAMIDE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LY 202472; POTASSIUM CHANNEL; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0029816510     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.3.415     Document Type: Article

References (39)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
2. Mizumura T, Nithipatikom K, Gross GJ. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation. 1995;92:1236-1245.
3. Yao Z, Gross GJ. Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs. Am J Physiol. 1994;261(Heart Circ Physiol 36):H1888-H1894.
4. Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation. 1992;86:979-985.
5. 1-selective adenosine analogues protects the heart against infarction. Circulation. 1992;85:659-665.
6. Liu Y, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-356.
7. Schultz R, Rose J, Post H, Heusch G. Involvement of endogenous adenosine in ischemic preconditioning in swine. Pflugers Arch. 1995;430:273-282.
8. 1 receptor binding by 2-amino-3-benzoylthiophenes. Mol Pharmacol. 1990;38:950-958.
9. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol Pharmacol 1990;38:939-949.
10. Mudumbi RV, Montamat SC, Bruns RF, Vestal RE. Cardiac functional responses to adenosine by PD 81,723, an allosteric enhancer of the adenosine A, receptor. Am J Physiol. 1993;264:H1017-H1022.
11. 1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart. J Pharmacol Exp Ther. 1993;266:611-617.
12. 1 adenosine receptor coupling to G proteins. Biochem Biophys Acta. 1995;1265:15-21.
13. Kirsch GE, Codina J, Birnbaumer L, Brown AM. Coupling of ATP sensitive K channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol. 1990;259:H820-H826.
14. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223-233.
15. Niiya K, Uchida S, Tsuji T, Olsson RA. Glibenclamide reduces the coronary vasoactivity of adenosine receptor agonists. J Pharmacol Exp Ther. 1994;271:14-19.
16. ATP channels, and ischemic preconditioning in dogs. Am J Physiol. 1993;264:H1327-H1336.
17. Auchampach JA, Caughey GA, Linden J. Molecular cloning and pharmacological characterization of the canine A3 adenosine receptor from BR mastocytoma cells. Mol Pharmacol. In press.
18. 1 adenosine receptors in heart. Circ Res. 1985;56:279-284.
19. 125I]iodophenyl)ethylamino]-adenosine. Mol Pharmacol. 1995;47:307-313.
20. Cullen BR. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 1987;152:684-704.
21. Ovize M, Przyklenk K, Hale SL, Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation. 1992;85:2247-2254.
22. Lasley RD, Rhee JW, Van Wylen DGL, Mentzer RM Jr. Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol. 1990;22:39-47.
23. Zhao ZQ, McGee DS, Nakanishi K, Toombs CF, Jonnston WE, Ashar MS, Vinten-Johansen J. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit Circulation. 1993;88:709-719.
24. Yokota R, Fujiwara H, Miyamae M, Tanaka M, Yamasaki K, Itoh S, Koga K, Yabuuchi Y, Sasayama S. Transient adenosine infusion before ischemia and reperfusion protects against metabolic damage in pig hearts. Am J Physiol. 1995;268:H1149-H1157.
25. Zhao ZQ, Williams MW, Sato H, Hudspeth DA, McGee DS, Vinten-Johansen J, Van Wylen DGL. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism. Cardiovasc Res. 1995;29:495-505.
26. 1 adenosine receptors: two amino acids are responsible for species differences in ligand recognition. J Biol Chem. 1994;269:27900-27906.
27. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 1994;15:298-306.
28. 3 receptor can mediate preconditioning's protection in isolated rabbit hearts. Cardiovasc Res. 1994;28:1057-1061.
29. 3 receptor involvement. Cardiovasc Res. 1994;28:1049-1056.
30. Schultz R, Jochen R, Heusch G. Involvement of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol. 1994;27:H1341-H1352.
31. Grover GJ, Sleph PG, Dzwonczyk S. Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1 receptors. Circulation. 1992;86:1310-1316.
32. + channels: implication for ischemic preconditioning. Circulation. 1994;90(pt 2):I-108. Abstract
33. Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res. 1993;27:617-622.
34. + channel in guinea pig ventricular cell membrane. J Physiol (Lond). 1994;478:101-107.
35. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266:H1145-H1152.
36. + currents by protein kinase C and adenosine: implications for ischemic preconditioning. Circ Res. 1996;78:443-454.
37. + channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP. Proc Natl Acad Sci USA. 1989;86:2971-2975.
38. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation. 1995;92:1546-1557.
39. Niroomand F, Weinbrenner C, Weis A, Bangert M, Schwencke C, Marquetant R, Beyer T, Strasser RH, Kübier W, Rauch B. Impaired function of inhibitory G proteins during acute myocardial ischemia of canine hearts and its reversal during reperfusion and a second period of ischemia: possible implications for the protective mechanism of ischemic preconditioning. Circ Res. 1995;76;861-870.